Multiple sclerosis medicine Zinbryta no longer authorised as its risks outweigh its benefits.
- Published in:
- Medical Writing, 2018, v. 27, n. 3, p. 48
- By:
- Publication type:
- Article
Works matching DE "EUROPEAN Medicines Agency. Pharmacovigilance Risk Assessment Committee"
Results: 3
1
2
Forum.
- Published in:
- Pharmaceutical Medicine, 2015, v. 29, n. 3, p. 183, doi. 10.1007/s40290-015-0101-y
- Publication type:
- Article
3
Europe advises against codeine for kids.
- Published in:
- Australian Journal of Pharmacy, 2013, v. 94, n. 1119, p. 5
- Publication type:
- Article